# Michael J. Eck

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-j-eck/

## Facts

| Field | Value |
| --- | --- |
| Citations | 47,900 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 91 |
| i10-index | 161 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5041782093 |
| ORCID iD | https://orcid.org/0000-0003-4247-9403 |
| Works | 421 |

## Researcher papers

- [<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy](https://scholariq.org/papers/i-egfr-i-mutations-in-lung-cancer-correlation-with-clinical-response-to/)
- [<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib](https://scholariq.org/papers/i-egfr-i-mutation-and-resistance-of-non-small-cell-lung-cancer-to-gefitinib/)
- [Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer](https://scholariq.org/papers/structural-biochemical-and-clinical-characterization-of-epidermal-growth-factor/)
- [Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer](https://scholariq.org/papers/mutations-in-the-i-ddr2-i-kinase-gene-identify-a-novel-therapeutic-target-in/)
- [The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers](https://scholariq.org/papers/the-neuroblastoma-associated-f1174l-alk-mutation-causes-resistance-to-an-alk/)
- [Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy](https://scholariq.org/papers/bronchial-and-peripheral-murine-lung-carcinomas-induced-by-t790m-l858r-mutant/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.